NIPT Yourgene Health Q1 Preliminary Revenues Rise 80 Percent The company also reported a 10 percent increase in fiscal year 2021 revenues, in line with its unaudited results. Progenity, Natera Jointly Request Dismissal of Patent Litigation Progenity sought a declaratory judgment from a California court last year that its Innatal NIPT test didn't infringe six patents held by Natera. Sema4 Closes SPAC Deal With CM Life Sciences, Raising Approximately $500M Premium The genetic testing and health intelligence firm will start trading on the Nasdaq Global Select Market on Friday under the ticker symbols SMFR and SMFRW. Natera Inks Distribution Deal With TomaLab for Italy The deal covers three of Natera's tests including its Signatera circulating tumor DNA test for cancer treatment monitoring and minimal residual disease assessment. BillionToOne Adapting Fetal Dx Tech for Liquid Biopsy, Cancer Therapy Response Monitoring Premium The company believes its molecular counting technology can offer improved sensitivity for advanced cancer genotyping and longitudinal monitoring of response to therapy. Jun 14, 2021 BillionToOne Raises $55M in Series B Financing Jun 2, 2021 Progenity to Close Genetics Lab as Focus Shifts to Therapeutics May 26, 2021 Illumina, Roche Agree to Settle NIPT Patent Lawsuits May 19, 2021 Yourgene, Alliance Global Sign Distribution Deal for Middle East, Africa May 3, 2021 Echelon Diagnostics, Cradle Genomics Ink Noninvasive Prenatal Diagnostics Partnership Apr 14, 2021 Arcedi Biotech Introduces NIPT Analyzing DNA From Rare Fetal Cells in Maternal Blood Premium Mar 18, 2021 Progenity Q4 Revenues Fall 30 Percent on COVID-19 Effect Feb 26, 2021 Natera Launches Tumor Genomic Profiling Assay, Expects Reproductive Health to Break Even This Year Premium Feb 25, 2021 Natera Revenues Grow 35 Percent in Q4 Feb 10, 2021 Tataa Biocenter Takes Majority Stake in Swedish Genetic Testing Firm Life Genomics Jan 14, 2021 Progenity Projects 2021 Revenue Growth of Up to 30 Percent Dec 3, 2020 Aetna Updates Noninvasive Prenatal Testing Coverage Policy to Include All Pregnancies Dec 1, 2020 UnitedHealthcare to Cover NIPT for Average-Risk Pregnancies Nov 19, 2020 Progenity to Cut Workforce as Third-Party Payor Seeks $27.4M for Alleged Overpayment Nov 16, 2020 Myriad Genetics Bets Fetal DNA Enrichment Method Will Further Increase Uptake of NIPS Test Premium Nov 9, 2020 Progenity Q3 Revenues Increase 38 Percent Nov 6, 2020 Natera Expects Further Growth in NIPT as it Expands Use Cases for Cancer, Transplant Tests Premium Nov 5, 2020 Natera Q3 Revenues Up 26 Percent on Increased Testing Volumes Oct 29, 2020 Humana Broadens Coverage of NIPT for Average Risk Pregnancies Oct 26, 2020 Yourgene H1 Revenues Up 5 Percent Load More Breaking News Ancient DNA Analysis Highlights Three Ancestral Populations in Japan FDA Warns of Potential False Positives With Abbott SARS-CoV-2 Molecular Tests New Products Posted to GenomeWeb: Oxford Nanopore, Beckman Coulter, Thermo Fisher Scientific, More People in the News: New Appointments at Sema4, NHGRI, Dante Labs, Ancestry, More Thermo Fisher Scientific Expects 12 Percent Revenue Growth in 2022 In Brief This Week: Myriad Genetics, Danaher, Co-Diagnostics, and More The Scan For Those Thick Tiger Stripes Tigers in India with thick stripes harbor a genetic change, as Gizmodo reports. High GABA Tomatoes The Japan News reports that genome-edited tomatoes with higher GABA levels are now for sale in Japan. Approach for Inclusivity and Diversity A National Human Genome Research Institute team calls for the field to "adopt diversity as an ethos." Science Papers on Tumors Immune System Evasion; Drivers of Genomic Instability, Inflammation In Science this week: study of how tumors evade the adaptive immune system, and more.